• 1
    Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527530.
  • 2
    Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992; 255:11371141.
  • 3
    Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335:256259.
  • 4
    Lieber MR, Hesse JE, Lewis S et al. The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell 1988; 55:716.
  • 5
    Blunt T, Finnie NJ, Taccioli GE et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995; 80:813823.
  • 6
    Blunt T, Gell D, Fox M et al. Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci USA 1996; 93:1028510290.
  • 7
    Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68:869877.
  • 8
    Shinkai Y, Koyasu S, Nakayama K et al. Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes. Science 1993; 259:822825.
  • 9
    Dorshkind K, Pollack SB, Bosma MJ, Phillips RA. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (SCID). J Immunol 1985; 134:37983801.
  • 10
    Ljunggren HG, Karre K. In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990; 11:237244.
  • 11
    Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997; 186:12691275.
  • 12
    van Rijn RS, Simonetti ER, Hagenbeek A et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2–/– gammac–/– double-mutant mice. Blood 2003; 102:25222531.
  • 13
    Gimeno R, Weijer K, Voordouw A et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2–/– gammac–/– mice: functional inactivation of p53 in developing T cells. Blood 2004; 104:38863893.
  • 14
    Legrand N, Cupedo T, van Lent AU et al. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in ‘human immune system’ Rag2(–/–)gammac(–/–) mice. Blood 2006; 108:238245.
  • 15
    Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 2006; 176:20532058.
  • 16
    Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 1980; 29:113.
  • 17
    Hudson WA, Li Q, Le C, Kersey JH. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects. Leukemia 1998; 12:20292033.
  • 18
    Watanabe Y, Takahashi T, Okajima A et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). Int Immunol 2009; 21:843858.
  • 19
    Ogasawara K, Hamerman JA, Hsin H et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003; 18:4151.
  • 20
    Matsumura T, Kametani Y, Ando K et al. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells. Exp Hematol 2003; 31:789797.
  • 21
    Ito M, Kobayashi K, Nakahata T. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol 2008; 324:5376.
  • 22
    Wege AK, Melkus MW, Denton PW, Estes JD, Garcia JV. Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008; 324:149165.
  • 23
    Ito R, Katano I, Kawai K et al. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 2009; 87:16541658.
  • 24
    Imadome K, Yajima M, Arai A et al. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog 2011; 7:e1002326.
  • 25
    King MA, Covassin L, Brehm MA et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157:104118.
  • 26
    Hayward SL, Bautista-Lopez N, Suzuki K, Atrazhev A, Dickie P, Elliott JF. CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice. J Immunol 2006; 176:77157725.
  • 27
    Cosgrove D, Gray D, Dierich A et al. Mice lacking MHC class II molecules. Cell 1991; 66:10511066.
  • 28
    Nabozny GH, Baisch JM, Cheng S et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med 1996; 183:2737.
  • 29
    Shultz LD, Saito Y, Najima Y et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci USA 2010; 107:1302213027.
  • 30
    Jaiswal S, Pearson T, Friberg H et al. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-SCID IL2rgammanull mice. PLoS ONE 2009; 4:e7251.
  • 31
    Danner R, Chaudhari SN, Rosenberger J et al. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE 2011; 6:e19826.
  • 32
    Cooke KR, Hill GR, Crawford JM et al. Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998; 102:18821891.
  • 33
    Covassin L, Laning J, Abdi R et al. Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rgamma(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen d-related 4) mice: a mouse model of human allogeneic graft-versus-host disease. Clin Exp Immunol 2011; 166:269280.